Skip to content

Welcome to Discover Pharma! Today is : October 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotechnology

  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development

    Icosagen completes €45M biologics manufacturing expansion

    Estonian biotechnology company Icosagen has completed a €45 million expansion [...]

    July 2, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    BioInnovation Institute expands into UK with London cardiometabolic innovation hub

    BioInnovation Institute has opened its first international base in London [...]

    June 29, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Verdiva Bio unveils obesity drug data ahead of planned clinical entry

    Verdiva Bio has reported new preclinical data for two obesity [...]

    June 9, 2026
  • Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    Society for RNA Therapeutics expands leadership team

    The Society for RNA Therapeutics (SRT) has expanded its leadership [...]

    June 8, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Apoha raises $36M to expand molecular behaviour data platform

    London-based technology company Apoha has emerged from stealth with $36 [...]

    June 8, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema

    Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion

    Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

    May 5, 2026
  • Biotech & Pharma Business,Pharmaceuticals and therapeutics

    Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership

    Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    TECregen appoints Dr Klaas Zuideveld as CEO to advance thymus regeneration platform

    TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Medical devices,Pharmaceuticals and therapeutics

    Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation

    Lithuania’s life sciences sector is preparing to showcase its rapid [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nabsys EGM detects genomic abnormalities in five-sample leukemia study
    Categories: Genomics and sequencing, Research & Development, Therapeutic Areas
  • Calibre secures CQC registration for nationwide AI health service
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Pharmaceuticals and therapeutics, Research & Development
  • Cyllene gene therapy for bladder disorder gains FDA RMAT designation
    Categories: Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top